SHIGERU has invested €8 million in Azalea Vision's Series A funding round to support the development of smart contact lenses for light sensitivity and eye disease treatment.
Target Information
In July 2021, SHIGERU participated in an €8 million Series A funding round aimed at supporting Azalea Vision's development of smart contact lenses designed for light sensitivity and eye disease treatments. Azalea Vision is a pioneering company focused on innovative solutions in ocular health, leveraging advanced technology to address unmet medical needs in eye care.
These smart contact lenses are anticipated to significantly enhance the quality of life for individuals suffering from various eye conditions. By combining technology with medical therapies, Azalea Vision aims to deliver effective and user-friendly solutions to patients.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The eye care industry in Europe is witnessing substantial growth, driven by advancing technologies and an increasing prevalence of eye disor
Similar Deals
China Development Industrial Bank → Anbogen Therapeutics
2024
SHIGERU
invested in
Azalea Vision
in 2021
in a Series A deal
Disclosed details
Transaction Size: $8M